|
|
| Fresenius Kabi Oncology Limited |
|
Financials-Fresenius Kabi Oncology Limited| Sector: Formulations | | BSE:32545 | NSE:FKONCO | Bloomberg:FKOL@IN | Reuters:FRES.BO | | Market Lot: 1 | Face Value: 1 | ISIN Demat: INE575G01010 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
30-Sep-2013(3) |
30-Sep-2012(3) |
% Change |
| Sales of Products/Services |
815.64 |
1512.59 |
-46.08 |
| Other Operating Income |
145.84 |
132.72 |
9.89 |
| Other Income |
0.03 |
5.03 |
-99.40 |
| Total Income |
961.51 |
1650.33 |
-41.74 |
| Total Expenses |
1250.31 |
1165.22 |
7.30 |
| OPBDIT |
-288.80 |
485.11 |
NM |
| Interest |
73.16 |
72.92 |
0.33 |
| Depreciation |
75.35 |
64.02 |
17.70 |
| Exceptional & Extraordinary Items |
0.00 |
0.00 |
-- |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
10.64 |
78.63 |
-86.47 |
| After Tax Profit |
-447.95 |
269.55 |
NM |
| Equity Capital |
158.23 |
158.23 |
0.00 |
| Reserves |
0.00 |
0.00 |
-- |
| Notes to Accounts |
Click here |
Click here |
|
|
| As on( Months ) |
31-Mar-07(12) |
|
31-Mar-06(12) |
|
31-Mar-05(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
2990.37 |
99.60 |
2462.09 |
98.99 |
2138.08 |
97.19 |
| Operating Income (OI) |
3002.30 |
100.00 |
2487.30 |
100.00 |
2199.97 |
100.00 |
| OPBDIT |
393.50 |
13.11 |
304.83 |
12.26 |
296.20 |
13.46 |
| OPBDT |
326.07 |
10.86 |
275.82 |
11.09 |
280.38 |
12.74 |
| OPBT |
248.28 |
8.27 |
198.17 |
7.97 |
245.56 |
11.16 |
| Non-Operating Income |
50.82 |
1.69 |
25.08 |
1.01 |
35.36 |
1.61 |
| Extraordinary/Prior Period |
-4.48 |
-0.15 |
-10.22 |
-0.41 |
-33.34 |
-1.52 |
| Tax |
42.10 |
1.40 |
27.53 |
1.11 |
22.03 |
1.00 |
| Profit after tax(PAT) |
252.53 |
8.41 |
185.49 |
7.46 |
225.55 |
10.25 |
| Cash Profit |
330.31 |
11.00 |
263.14 |
10.58 |
260.37 |
11.84 |
| Dividend-Equity |
0.00 |
0.00 |
31.22 |
1.26 |
14.36 |
0.65 |
|
| As on |
31-Mar-06 |
|
31-Mar-05 |
|
31-Mar-04 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
920.27 |
22.90 |
821.95 |
26.73 |
683.07 |
28.60 |
| Net Block |
708.38 |
17.63 |
648.30 |
21.08 |
537.19 |
22.49 |
| Capital WIP |
316.93 |
7.89 |
71.56 |
2.33 |
59.41 |
2.49 |
| Investments |
1297.52 |
32.29 |
1262.52 |
41.05 |
846.85 |
35.45 |
| Inventory |
557.59 |
13.88 |
579.41 |
18.84 |
423.75 |
17.74 |
| Receivables |
410.71 |
10.22 |
335.30 |
10.90 |
314.78 |
13.18 |
| Other Current Assets |
727.50 |
18.10 |
178.31 |
5.80 |
206.70 |
8.65 |
| Balance Sheet Total(BT) |
4018.62 |
100.00 |
3075.39 |
100.00 |
2388.69 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
156.08 |
3.88 |
143.65 |
4.67 |
0.50 |
0.02 |
| Reserves |
2871.92 |
71.47 |
2057.66 |
66.91 |
1842.36 |
77.13 |
| Total Debt |
526.81 |
13.11 |
479.51 |
15.59 |
134.04 |
5.61 |
| Creditors and Acceptances |
274.14 |
6.82 |
244.02 |
7.93 |
113.95 |
4.77 |
| Other current liab/prov. |
189.67 |
4.72 |
150.56 |
4.90 |
297.85 |
12.47 |
| Balance Sheet Total(BT) |
4018.62 |
100.00 |
3075.39 |
100.00 |
2388.69 |
100.00 |
|
| As on |
31-Mar-07 |
31-Mar-06 |
31-Mar-05 |
| OPBIT/Prod.cap.empl.(%) |
12.45 |
11.71 |
19.41 |
| PBIT/Cap. Employed (%) |
9.38 |
7.48 |
10.09 |
| PAT/Networth (%) |
7.60 |
6.13 |
10.25 |
| Tax/PBT (%) |
14.29 |
12.92 |
8.90 |
| Total Debt/Networth (x) |
0.44 |
0.17 |
0.22 |
| Long Term Debt/Networth (x) |
0.16 |
0.00 |
0.00 |
| PBDIT/Finance Charges (x) |
6.52 |
11.02 |
18.85 |
| Current Ratio (x) |
3.57 |
3.66 |
2.77 |
| RM Inventory (days consumption) |
193.98 |
267.83 |
275.67 |
| FG inventory (days cost of sales) |
28.83 |
20.52 |
22.72 |
| Receivables (days gross sales) |
66.81 |
57.60 |
54.29 |
| Creditors (days cost of sales) |
52.41 |
45.85 |
46.78 |
| Op. curr. assets (days OI) |
175.00 |
180.00 |
180.00 |
|
|
Financials